DEA / Prescribing of Controlled Substances

On May 9, the DEA announced that it will be extending flexibilities regarding telemedicine prescribing of controlled substances until November 11th, 2023 for new patients and until November 11th, 2024 for established patients. APA is working on getting more in-depth resources out to its members. You may read the federal announcements below.  

Recent Stories